CNST Constellation Pharmaceuticals Inc

Price (delayed)

$20.27

Market cap

$971.23M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.04

Enterprise value

$857.38M

Sector: Healthcare
Industry: Biotechnology

Highlights

CNST's debt has plunged by 92% YoY and by 20% from the previous quarter
The equity has increased by 20% YoY but it has decreased by 8% from the previous quarter
The quick ratio fell by 18% YoY but it rose by 9% QoQ
The net income has plunged by 54% YoY and by 12% from the previous quarter
The EPS has decreased by 8% from the previous quarter and by 5% YoY

Key stats

What are the main financial stats of CNST
Market
Shares outstanding
47.91M
Market cap
$971.23M
Enterprise value
$857.38M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.57
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$138.95M
EBITDA
-$138.25M
Free cash flow
-$126.49M
Per share
EPS
-$3.04
Free cash flow per share
-$2.64
Book value per share
$7.88
Revenue per share
$0
TBVPS
$8.42
Balance sheet
Total assets
$402.66M
Total liabilities
$25.34M
Debt
$3.37M
Equity
$377.32M
Working capital
$364.61M
Liquidity
Debt to equity
0.01
Current ratio
15.39
Quick ratio
15.21
Net debt/EBITDA
0.82
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-29.9%
Return on equity
-33.1%
Return on invested capital
-43.6%
Return on capital employed
-36.8%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CNST stock price

How has the Constellation Pharmaceuticals stock price performed over time
Intraday
5.57%
1 week
-2.55%
1 month
-12.18%
1 year
-53.27%
YTD
-29.62%
QTD
-13.34%

Financial performance

How have Constellation Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$139.09M
Net income
-$140.99M
Gross margin
N/A
Net margin
N/A
The net income has plunged by 54% YoY and by 12% from the previous quarter
The operating income has dropped by 51% year-on-year and by 11% since the previous quarter

Growth

What is Constellation Pharmaceuticals's growth rate over time

Valuation

What is Constellation Pharmaceuticals stock price valuation
P/E
N/A
P/B
2.57
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has decreased by 8% from the previous quarter and by 5% YoY
The equity has increased by 20% YoY but it has decreased by 8% from the previous quarter
The P/B is 13% below the last 4 quarters average of 2.8

Efficiency

How efficient is Constellation Pharmaceuticals business performance
The ROIC has grown by 50% YoY but it has contracted by 7% from the previous quarter
The ROE has grown by 31% YoY but it has contracted by 7% from the previous quarter
The ROA has grown by 19% YoY but it has contracted by 10% from the previous quarter

Dividends

What is CNST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CNST.

Financial health

How did Constellation Pharmaceuticals financials performed over time
Constellation Pharmaceuticals's total liabilities has plunged by 56% YoY and by 19% from the previous quarter
The quick ratio fell by 18% YoY but it rose by 9% QoQ
CNST's debt is 99% less than its equity
CNST's debt has plunged by 92% YoY and by 20% from the previous quarter
The debt to equity has dropped by 92% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.